中 / EN
2026-09-28 00:00 China Clinical Recruitment & Enrollment Source language EN

Bengbu Hospital Tests BCI Neurofeedback for Gaming Disorder in 120-Person Trial

Summary The First Affiliated Hospital of Bengbu Medical University, in eastern China's Anhui province, is recruiting for a clinical trial that uses brain-computer interface (BCI) neurofeedback to treat the cognitive-control deficits that keep people with internet gaming disorder from stopping play. The system reads frontal midline theta rhythms and feeds them back in real time so participants learn to regulate their own brain activity, with social rewards built in as reinforcers to improve efficacy and adherence. The trial plans to enroll 120 patients across three arms: dual-target neurofeedback plus social reward, neurofeedback alone, and sham feedback. Primary completion is expected on December 30, 2028.
Why it matters Gaming disorder has almost no treatments aimed at the underlying brain circuitry, and the trial's neurofeedback-only and sham arms let it separate what the brain-signal training and the social rewards each contribute, though no results will be available before late 2028.

BCIwiki (bciwiki.com) — A clinical trial led by The First Affiliated Hospital of Bengbu Medical University is recruiting people with internet gaming disorder to test whether dual-target neurofeedback training based on a brain-computer interface (BCI) can improve cognitive control. The trial, NCT07843615, was first posted on ClinicalTrials.gov on September 28, 2026. It actually began on January 1, 2026, is currently recruiting, and plans to enroll 120 participants.

The protocol addresses three gaps in research on cognitive control deficits in the disorder: unclear neural mechanisms, limited intervention targets and poor patient adherence. The team proposes a disease model in which declining social rewards lead to dysfunction of the dorsal anterior cingulate cortex-dorsolateral prefrontal cortex (dACC-DLPFC) cognitive control circuit, which shows up as abnormal frontal midline theta rhythm (Fmθ).

According to the protocol, the investigators built a dual-target system that combines neurofeedback with social reward substitution, turning social rewards into therapeutic reinforcers to strengthen the intervention. The trial has three arms: dual-target neurofeedback training that activates the circuit and promotes social rewards, neurofeedback training that activates the circuit only, and sham feedback.

The study is being conducted in China. Primary completion and study completion are both expected on December 30, 2028. No results have been posted.

Compiled by BCIwiki from public sources

Sources · 1
Read original ↗
Suggest a correction Revisions · none 中 / EN
© 2026 BCIwiki.com Digest Topics Tips Subscribe Revisions About